Citation Impact

Citing Papers

Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
2020 StandoutScience
Mapping the Antigenic and Genetic Evolution of Influenza Virus
2004 StandoutScience
Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
2021 StandoutScienceNobel
Influence of past reproductive performance on risk of spontaneous abortion.
1989
Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model
2010
Genetic variability of the AIDS virus: Nucleotide sequence analysis of two isolates from African patients
1986 StandoutNobel
Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection
2015
Immunologic correlates of protection induced by vaccination
2001
Vaccines: Correlates of Vaccine‐Induced Immunity
2008
Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial
1999 Standout
Comparative lung pathology of inbred strains of mice resistant and susceptible to Sendai virus infection.
1991
mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
2019
Ciprofloxacin: In Vitro Activity, Mechanism of Action, and Resistance
1988
Neural-Tube Defects
1999 Standout
Inducible Gene Targeting in Mice
1995 StandoutScience
Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein
1993 Standout
Universal coronavirus vaccines: the time to start is now
2020
Can a Short Period of Micronutrient Supplementation in Older Institutionalized People Improve Response to Influenza Vaccine? A Randomized, Controlled Trial
2003
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice
2020 StandoutNobel
Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children
2011
University of California/Davis Interdepartmental Conference on Gram-Negative Septicemia
1991 StandoutNobel
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
2005 Standout
The Effect of Folic Acid Fortification on Plasma Folate and Total Homocysteine Concentrations
1999 Standout
Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine
1995
Novel correlates of protection against pandemic H1N1 influenza A virus infection
2019
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
2020 StandoutNature
Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention
2007 Standout
Recurrent miscarriage
2006 Standout
Heterologous Epitope-Scaffold Prime∶Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant
2011 StandoutNobel
Human hemoglobin-derived peptides exhibit antimicrobial activity: a class of host defense peptides
2003
Transgenic mice with intracellular immunity to influenza virus
1990
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
2018 StandoutNobel
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
2021 Standout
SARS-CoV-2 vaccines in development
2020 StandoutNature
Prevention of Neural-Tube Defects with Folic Acid in China
1999 Standout
Resistance of Inbred Mice to Salmonella typhimurium
1972
High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses
1997
Induction of cytokines in mice with parainfluenza pneumonia
1995 StandoutNobel
Correlates of Protection against Influenza in the Elderly: Results from an Influenza Vaccine Efficacy Trial
2016
Central nervous system abnormalities ‐ contrasting patterns in early and late pregnancy
1978
BACTERICIDAL ACTION OF HISTONE
1958
Newcastle Disease Virus Expressing a Dendritic Cell-Targeted HIV Gag Protein Induces a Potent Gag-Specific Immune Response in Mice
2010 StandoutNobel
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
VIRAL ONCOLYSIS: INCREASED IMMUNOGENICITY OF HOST CELL ANTIGEN ASSOCIATED WITH INFLUENZA VIRUS
1967
Interaction of chlamydiae and host cells in vitro
1991
Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis
1994
Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection
2010
Chlamydia trachomatis and oral contraceptive use: a quantitative review.
1992
HOW CELLS RESPOND TO INTERFERONS
1998 Standout
Immunization of Primates with a Newcastle Disease Virus-Vectored Vaccine via the Respiratory Tract Induces a High Titer of Serum Neutralizing Antibodies against Highly Pathogenic Avian Influenza Virus
2007
Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system
1974 StandoutNatureNobel
Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation
2022 StandoutNobel
FURTHER EXPERIENCE OF VITAMIN SUPPLEMENTATION FOR PREVENTION OF NEURAL TUBE DEFECT RECURRENCES
1983
Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact
2016
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
2011 StandoutNobel
Roles of Infectious Agents in Atherosclerosis and Restenosis
1997 Standout
Cross‐protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity
1984
Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines
1981 StandoutNature
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes
2022 StandoutScienceNobel
Cachectin: More Than a Tumor Necrosis Factor
1987 StandoutNobel
Transcriptional activation of the mouse Mx gene by type I interferon.
1986
PHYLOGENETIC ORIGINS OF ANTIBODY STRUCTURE
1966 StandoutNobel
Neurovirulence of influenza virus in mice I. Neurovirulence of recombinants between virulent and avirulent virus strains
1980
HUMAN PAPILLOMAVIRUS INFECTIONS IN WOMEN WITH AND WITHOUT ABNORMAL CERVICAL CYTOLOGY
1987 StandoutNobel
Mx-dependent resistance to influenza viruses is induced by mouse interferons α and β but not γ
1984
MECHANISMS OF ACQUIRED RESISTANCE IN MOUSE TYPHOID
1966
Sendai virus infection in genetically resistant and susceptible mice.
1981
Molecular mechanisms of variation in influenza viruses
1982 Nature
Differential antigen burden modulates the gamma interferon but not the immunoglobulin response in mice that vary in susceptibility to Sendai virus pneumonia
1995 StandoutNobel
Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model
2016
The Danger Model: A Renewed Sense of Self
2002 StandoutScience
Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model
2017
Sequence studies of several alphavirus genomic RNAs in the region containing the start of the subgenomic RNA.
1982 StandoutNobel
INTERACTION OF THE RHEUMATOID FACTOR WITH ANTIGEN-ANTIBODY COMPLEXES AND AGGREGATED GAMMA GLOBULIN
1958 StandoutNobel
SENSITIZATION TO DENATURED AUTOLOGOUS GAMMA GLOBULIN
1962 StandoutNobel
Neutrophil Extracellular Traps Kill Bacteria
2004 StandoutScience
Characterization of Vesicular Stomatitis Virus Recombinants That Express and Incorporate High Levels of Hepatitis C Virus Glycoproteins
2002 StandoutNobel
Variable efficacy of repeated annual influenza vaccination
1999
Does the higher order structure of the influenza virus ribonucleoprotein guide sequence rearrangements in influenza viral RNA?
1983 StandoutNobel
The B-cell response in lymphoid tissue of mice immunized with various antigenic forms of the influenza virus hemagglutinin
1995 StandoutNobel
Studies on the Waaler-Rose Hemagglutination Test
1956
Operating Characteristics of a Rank Correlation Test for Publication Bias
1994 Standout
Human papillomavirus infection of the uterine cervix of women without cytological signs of neoplasia.
1986
Chlamydial Heat Shock Protein 60 Localizes in Human Atheroma and Regulates Macrophage Tumor Necrosis Factor-α and Matrix Metalloproteinase Expression
1998 Standout
Protection against lethal lymphocytic choriomeningitis virus (LCMV) infection by immunization of mice with an influenza virus containing an LCMV epitope recognized by cytotoxic T lymphocytes
1994 StandoutNobel
Mitogenic stimulation of murine spleen cells: relation to susceptibility to Salmonella infection
1977
Serum responses in rheumatoid arthritis
1959
PROPERTIES OF GUINEA PIG 7S ANTIBODIES
1963 StandoutNobel
The antigenic evolution of influenza: drift or thrift?
2013
Genome Sequence of an Obligate Intracellular Pathogen of Humans: Chlamydia trachomatis
1998 StandoutScience
The agglutination reaction in rheumatoid arthritis
1957
Vaccination with Adjuvanted Recombinant Neuraminidase Induces Broad Heterologous, but Not Heterosubtypic, Cross-Protection against Influenza Virus Infection in Mice
2015

Works of D. Hobson being referenced

Chlamydial infections of the urethra in women.
1985
The agglutinating property of complement
1952
A comparison of the in-vitro activity of antimicrobials against Chlamydia trachomatis examined by Giemsa and a fluorescent antibody stain
1985
Serological studies with purified neuraminidase antigens of influenza B viruses
1974
Genital infections with Chlamydia trachomatis in women attending an antenatal clinic
1984
Chlamydial infection of the cervix in contacts of men with nongonococcal urethritis.
1980
Effects of chloramphenicol onChlamydia trachomatisinfection in neonatal conjunctivitis and in McCoy cell cultures
1982
The effect of penicillin on genital strains of Chlamydia trachomatis in tissue culture
1977
Studies in vitro of the nature and synthesis of the cell wall ofChlamydia trachomatis
1984
AGGLUTINATION TEST FOR RHEUMATOID ARTHRITIS
1952
The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses
1972
THE ANTIBACTERIAL ACTIVITY OF HEMOGLOBIN
1958
Chronic bacterial carriage in survivors of experimental mouse typhoid
1957
Factors affecting the sensitivity of replicating McCoy cells in the isolation and growth of chlamydia A (TRIC agents)
1976
Amino acid requirements of a Chlamydia trachomatis genital strain in McCoy cell cultures
1981
The Inhibitor-destroying Activity of Influenza A Virus Strains of Differing Neurovirulence for Mice
1968
A COMPARISON OF LIVE AND KILLED INFLUENZA-VIRUS VACCINES
1968
The Resistance of A2G Mice to Myxoviruses
1963
Resistance to reinfection in experimental mouse typhoid
1957
Spina bifida and anencephaly: miscarriage as possible cause.
1975
EFFECT OF INFLUENZA VACCINES IN STIMULATING ANTIBODY IN VOLUNTEERS WITH PRIOR IMMUNITY
1973
Rankless by CCL
2026